5 December 2025VideosAISamuel Jinks, Haley Guiliano | Carola Lempke, AstraZeneca | Kritika Chhokra, BAT | David Degen, Novartis
WATCH: Reality check — debunking myths in AI adoption to overcome barriers and build trust
Speakers from Haley Guiliano, AstraZeneca, BAT, and Novartis examine the practical steps legal and IP teams can take to adopt AI responsibly, address scepticism, and build trust.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
3 December 2025 A cornerstone of the US economic plan just got new IP protection, so what does it mean for the ‘inventor’ and what should companies leveraging AI do next?